Shares of Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB – Get Free Report) dropped 9.7% during mid-day trading on Thursday . The company traded as low as $2.03 and last traded at $2.33. Approximately 30,161 shares traded hands during trading, an increase of 96% from the average daily volume of 15,418 shares. The stock had previously closed at $2.58.
Lakeshore Biopharma Stock Performance
The company has a current ratio of 1.13, a quick ratio of 0.87 and a debt-to-equity ratio of 0.17. The stock’s 50 day simple moving average is $4.89.
Lakeshore Biopharma Company Profile
LakeShore Biopharma Co, Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.
Further Reading
- Five stocks we like better than Lakeshore Biopharma
- There Are Different Types of Stock To Invest In
- Battle of the Retailers: Who Comes Out on Top?
- How to Use the MarketBeat Stock Screener
- HCA Healthcare: Temporary Setbacks, Long-Term Strength
- Options Trading – Understanding Strike Price
- MarketBeat Week in Review – 10/28 – 11/1
Receive News & Ratings for Lakeshore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeshore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
-PORTAL.png?v=2024-02-28&h=45&w=95&zc=2){kind=small}